# A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

> **NCT01537705** · PHASE2 · UNKNOWN · sponsor: **Targeted Medical Pharma** · enrollment: 24 (estimated)

## Conditions studied

- Diabetic Neuropathy
- Chemotherapy Induced Neuropathy
- HIV Neuropathy
- Trauma Induced Neuropathy

## Interventions

- **DRUG:** Neuron012703 (Medical Food)

## Key facts

- **NCT ID:** NCT01537705
- **Lead sponsor:** Targeted Medical Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2012-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537705, "A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01537705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*